和誉-B(02256)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02256 和誉-B

交易中 06-29 15:57:55

10.460

+1.100

+11.75%

最高10.470	最低9.550	成交量445.80万
今开9.550	昨收9.360	日振幅9.83%
总市值74.89亿	流通市值74.89亿	总股本7.16亿
成交额4,547万	换手率0.62%	流通股本7.16亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02256","market":"HK","secType":"STK","nameCN":"和誉-B","latestPrice":10.46,"timestamp":1782719871744,"preClose":9.36,"halted":0,"volume":4458000,"delay":0,"changeRate":0.11752136752136769,"floatShares":716000000,"shares":716000000,"eps":0.088442,"marketStatus":"交易中","change":1.1,"latestTime":"06-29 15:57:55","open":9.55,"high":10.47,"low":9.55,"amount":45465426,"amplitude":0.098291,"askPrice":10.47,"askSize":31000,"bidPrice":10.44,"bidSize":4000,"shortable":3,"etf":0,"ttmEps":0.085,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1782720600000},"marketStatusCode":2,"adr":0,"listingDate":1634054400000,"exchange":"SEHK","adjPreClose":9.36,"openAndCloseTimeList":[[1782696600000,1782705600000],[1782709200000,1782720000000]],"volumeRatio":2.498651,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02256","defaultTab":"news","newsList":[{"id":"2647231533","title":"港股异动 | 和誉-B(02256)涨超11% 近期公布ABSK061联合ABSK043治疗FGFR2阳性晚期GC/GEJC II期研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2647231533","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647231533?lang=zh_cn&edition=full","pubTime":"2026-06-29 13:43","pubTimestamp":1782711808,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，和誉-B涨超11%，截至发稿，涨9.08%，报10.21港元，成交额2366.89万港元。研究数据显示，ABSK061联合ABSK043，伴或不伴CAPOX，在FGFR2阳性晚期GC/GEJC患者中展现出良好的安全性和积极的抗肿瘤活性，凸显了这种靶向联合免疫治疗策略作为该患者群体新型治疗方案的潜力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1460217.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B543WZ88.USD","LU2476274308.USD","BK4588","LU2778985437.USD","BK4585","BK1161","LU2488822045.USD","VXUS","LU2476274720.SGD","IE00BPRC5H50.USD","02256","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646467351","title":"和誉-B(02256)6月26日斥资38.3万港元回购4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2646467351","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646467351?lang=zh_cn&edition=full","pubTime":"2026-06-26 19:12","pubTimestamp":1782472374,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，于2026年6月26日斥资38.3万港元回购4万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1459582.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2488822045.USD","LU2476274308.USD","LU2778985437.USD","BK1161","IE00BPRC5H50.USD","02256","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU2476274720.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646368603","title":"和誉-B(02256)：和誉医药在2026 ASCO年会公布ABSK061联合ABSK043治疗FGFR2阳性晚期GC/GEJC II期研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2646368603","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646368603?lang=zh_cn&edition=full","pubTime":"2026-06-26 12:31","pubTimestamp":1782448306,"startTime":"0","endTime":"0","summary":"研究数据显示，ABSK061联合ABSK043，伴或不伴CAPOX，在FGFR2阳性晚期GC/GEJC患者中展现出良好的安全性和积极的抗肿瘤活性，凸显了这种靶向联合免疫治疗策略作为该患者群体新型治疗方案的潜力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1459246.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","159938","IE00BPRC5H50.USD","09939","BK1515","LU2476274720.SGD","LU2778985437.USD","IE00B543WZ88.USD","LU2476274308.USD","BK1574","LU2488822045.USD","02256","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144542752","title":"和誉-B回购3万股股份，总额约27.92万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1144542752","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144542752?lang=zh_cn&edition=full","pubTime":"2026-06-25 19:12","pubTimestamp":1782385966,"startTime":"0","endTime":"0","summary":"2026年6月25日，和誉-B发布翌日报表公告，披露当日于香港联交所场内回购3万股普通股，约占回购前已发行股本的0.00419%。本次回购价格区间介乎每股9.00港元至9.48港元，平均约9.306港元，合计付出价款约27.92万港元。根据公告信息，和誉-B于2026年5月20日通过了购回授权，目前尚余可购回股份数量为71,646,135股，并已于交易所完成累计回购410,000股，占授权通过当日已发行股份总数的0.05723%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"和誉-B回购3万股股份，总额约27.92万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646516872","title":"和誉-B(02256.HK)6月25日斥资约27.92万港元回购3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2646516872","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646516872?lang=zh_cn&edition=full","pubTime":"2026-06-25 19:07","pubTimestamp":1782385662,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BPRC5H50.USD","LU2476274308.USD","LU2476274720.SGD","LU2778985437.USD","LU2488822045.USD","BK1161","IE00B543WZ88.USD","IE00B5MMRT66.SGD","02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128231005","title":"匹米替尼获加拿大批准上市，和誉-B再升超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1128231005","media":"老虎资讯综合","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128231005?lang=zh_cn&edition=full","pubTime":"2026-06-25 14:53","pubTimestamp":1782370432,"startTime":"0","endTime":"0","summary":"和誉-B(02256)再升超4%，截至发稿，升4.14%，报9.8港元，成交额1965.35万港元。和誉医药自主研发的高选择性CSF-1R抑制剂匹米替尼（Pimicotinib）近日获加拿大卫生部批准上市，适用于治疗手术干预可能导致功能障碍恶化或严重并发症的TGCT患者。本次上市申请获优先审评资格，审批时间较常规流程大幅缩短约40%，凸显监管机构对该产品临床获益及创新价值的认可，也进一步验证了其全球商业化潜力。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/4ce4cc258a35d780cc2cb13be791f105","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/4ce4cc258a35d780cc2cb13be791f105"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646822458","title":"港股和誉-B涨超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646822458","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646822458?lang=zh_cn&edition=full","pubTime":"2026-06-25 14:52","pubTimestamp":1782370323,"startTime":"0","endTime":"0","summary":"6月25日，和誉-B(02256.HK)再涨超4%，截至发稿，涨4.14%，报9.8港元，成交额1965.35万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606253782990740.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606253782990740.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02256","BK4585","BK4588","BK1161","LU2476274308.USD","VXUS","LU2476274720.SGD","IE00B5MMRT66.SGD","LU2488822045.USD","LU2778985437.USD","IE00BPRC5H50.USD","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646382250","title":"港股异动 | 和誉-B(02256)再涨超4% 匹米替尼加拿大获批上市 产品正式渐入全球商业化价值兑现阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2646382250","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646382250?lang=zh_cn&edition=full","pubTime":"2026-06-25 14:45","pubTimestamp":1782369905,"startTime":"0","endTime":"0","summary":"消息面上，近日，和誉医药自主研发的高选择性CSF-1R小分子抑制剂匹米替尼已正式获得加拿大卫生部批准上市，用于治疗手术切除可能导致功能障碍加重或引发严重并发症的TGCT患者。平安证券指出，匹米替尼正式获得加拿大卫生部批准上市，是继国内获批上市的第二个全球上市批准，也意味着匹米替尼正式渐入全球商业化价值兑现阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1458589.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BPRC5H50.USD","02256","LU2476274308.USD","IE00B5MMRT66.SGD","LU2476274720.SGD","LU2778985437.USD","BK4585","LU2488822045.USD","BK1161","IPOS","VXUS","IE00B543WZ88.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646822565","title":"【券商聚焦】平安证券维持和誉(02256)“推荐”评级 指全球商业化价值逐步兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=2646822565","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646822565?lang=zh_cn&edition=full","pubTime":"2026-06-25 14:38","pubTimestamp":1782369528,"startTime":"0","endTime":"0","summary":"金吾财讯 | 平安证券研报指，和誉-B 核心品种匹米替尼国内、加拿大已获批上市治疗TGCT，FGFR4抑制剂治疗肝癌已进入注册性临床试验，且持续推进早期在研管线进展。考虑到公司核心产品匹米替尼刚进入商业化放量初期，产品市场渗透率逐步提升；2026年6月公司确认了默克支付的里程碑付款1352万美元，后续里程碑付款触发时点和金额将受全球审批进度、商业化销售等影响。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/MTU3MGM5Y2M3ZDk5Mjg2ODIwNjM2NDU0OA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MTU3MGM5Y2M3ZDk5Mjg2ODIwNjM2NDU0OA==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984497","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189499088","title":"和誉-B6月24日回购5万股股份，总额约46.92万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1189499088","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189499088?lang=zh_cn&edition=full","pubTime":"2026-06-24 18:12","pubTimestamp":1782295961,"startTime":"0","endTime":"0","summary":"2026年6月24日，和誉开曼有限责任公司于香港联交所公布翌日披露报表，宣布当日在场内回购普通股5万股。本次回购股份数量占回购前公司已发行股份总数约0.00698%，每股回购价格介乎9.35港元至9.42港元，合计耗资约46.92万港元。完成此次回购后，公司已发行股份总数维持724,205,350股，其中流通股为716,081,350股，库藏股增至8,124,000股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"和誉-B6月24日回购5万股股份，总额约46.92万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645891767","title":"和誉-B(02256.HK)6月24日斥资46.92万港元回购5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645891767","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645891767?lang=zh_cn&edition=full","pubTime":"2026-06-24 18:09","pubTimestamp":1782295777,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2476274720.SGD","IE00B543WZ88.USD","IE00BPRC5H50.USD","LU2778985437.USD","02256","LU2476274308.USD","LU2488822045.USD","BK1161","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645986581","title":"创新药BD再添重磅！和誉医药牵手礼来，潜在交易规模达19亿美元｜医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2645986581","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645986581?lang=zh_cn&edition=full","pubTime":"2026-06-24 09:44","pubTimestamp":1782265469,"startTime":"0","endTime":"0","summary":"截至6月23日收盘，市场震荡调整，医药板块逆势走强。医药ETF（512120）上涨0.74%，港股通生物科技ETF（159102）换手率6.95%。相关个股中，晶态控股上涨5.05%，康方生物上涨3.07%，三生制药上涨2.11%。消息面上，6月24日，和誉医药宣布其已与全球领先制药企业EliLillyandCompany（“礼来”）签署战略研究合作及授权协议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606243780748569.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606243780748569.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1069344957.HKD","SG9999017495.SGD","LU1291159041.SGD","LU2089284900.SGD","LU2271345857.HKD","LU0096364046.USD","LU0158827781.USD","LU0320765992.SGD","LU0353189680.USD","LU1629891620.HKD","LU2476274308.USD","BK4599","LU0094547139.USD","LU1232071149.USD","LU0109394709.USD","LU1267930730.SGD","LU2471134796.USD","SG9999015978.USD","BK4007","LU2168563687.JPY","LU1127390331.HKD","LU1983299246.USD","LU0640476718.USD","LU0787776722.HKD","LU1023059063.AUD","LU2476274720.SGD","BK4585","LU0353189763.USD","LU2237443978.SGD","LU0354030438.USD","LU2360106947.USD","LU1868837136.USD","SGXZ57979304.SGD","LU2168564495.EUR","IE0005OL40V9.USD","LU1057294990.SGD","ELIS","IE00BFTCPJ56.SGD","IE00B7KXQ091.USD","LU2211815571.USD","IE00B4R5TH58.HKD","LU0385154629.USD","LU2023250504.SGD","LU2456880835.USD","SG9999018857.SGD","LU0203201768.USD","LLYX","LU2237438978.USD","LU0786609619.USD","LU1323610961.USD","LU0320765059.SGD","IE0002141913.USD","LU2028103732.USD","SGXZ81514606.USD","SG9999018865.SGD","IE00BK4W5L77.USD","LU2491049909.HKD","SG9999015945.SGD","IE00BJJMRX11.SGD","IE0001KFT4U8.USD","SG9999014898.SGD","LU0471298694.HKD","LU1988902786.USD","LU2746668974.SGD","LU2108987350.USD","LU2471134523.USD","IE00B1BXHZ80.USD","LU1366192091.USD","LU2471134879.HKD","IE00BJT1NW94.SGD","LU2089283258.USD","LU2488822045.USD","LU0882574139.USD","BK4534","LU2023250330.USD","LU1093756325.SGD","IE00BFSS7M15.SGD","LU0889565916.HKD","LU0203202063.USD","LU2471134952.CNY","LU2896262040.SGD","LU1868837300.USD","LU0097036916.USD","SG9999013999.USD","LU2265009873.SGD","LU0114720955.EUR","LU1720051108.HKD","LU1712237335.SGD","LU2756315664.SGD","SG9999014880.SGD","LU0079474960.USD","IE00BN29S564.USD","LU2237443895.HKD","IE00B543WZ88.USD","LU0823416689.USD","LU2111349929.HKD","LU2237443465.HKD","IE00BKPKM429.USD","LU2552382215.SGD","IE0004445015.USD","LU2089984988.USD","LU2168564222.USD","IE00BPRC5H50.USD","LU0943347566.SGD","LU1868836591.USD","LU1061106388.HKD","LU0106261372.USD","IE00B1XK9C88.USD","LU1974910355.USD","LU2236285917.USD","LU1623119135.USD","LU2087625088.SGD","LLY","LU0882574055.USD","LU2112291526.USD","IE00B5MMRT66.SGD","LU2468319806.SGD","LU0820561818.USD","LU1989771016.USD","IE00BKDWB100.SGD","LLYZ","LU0289739699.SGD","LU2417539215.USD","SG9999001176.USD","BK4588","LU0432979614.USD","IE00BWXC8680.SGD","IE00B775H168.HKD","LU0061475181.USD","SG9999015986.USD","LU1280957306.USD","LU2357305700.SGD","LU2264538146.SGD","LU0133085943.USD","SG9999014906.USD","LU2063271972.USD","LU2237443382.USD","LU1145028129.USD","IE00BJLML261.HKD","LU0256863902.USD","LU0158827948.USD","LU1720051017.SGD","LU0225283273.USD","LU0708995401.HKD","LU0006306889.USD","LU1868836914.USD","IE0004445239.USD","LU2750360997.AUD","IE00BK4W5M84.HKD","LU0238689110.USD","LU2491050154.USD","BK4533","LU1814569148.SGD","IE00B4JS1V06.HKD","SG9999015952.SGD","LU0820561909.HKD","LU2168564065.EUR","LU0210536198.USD","LU0234572021.USD","LU2213496289.HKD","LU2462157665.USD","LU2602419157.SGD","BK4516","LU0323591593.USD","LU0316494557.USD","LU2023251221.USD","SG9999014914.USD","LU0354030511.USD","LU2237443549.SGD","LU0471298777.SGD","LU2552382132.HKD","LU2746668461.USD","LU0198837287.USD","LU1064131342.USD","SG9999001176.SGD","SGXZ99366536.SGD","IE0009355771.USD","02256","LU1035775433.USD","LU1551013425.SGD","LU0672654240.SGD","LU2461242641.AUD","LU1551013342.USD","LU2778985437.USD","IE00BJJMRY28.SGD","LU1548497426.USD","LU0823434740.USD","LU0109391861.USD","LU0058720904.USD","LLII","LU0823434583.USD","LU0456855351.SGD","LU2168564149.EUR","LU1804176565.USD","LU2361045086.USD","BK4581","LU1093756168.USD","LU0683600562.USD","LU0466842654.USD","SGXZ31699556.SGD","ELIL","LU0964807845.USD","IE00BFSS8Q28.SGD","LU2106854487.HKD","LU2552382058.USD","LU0266013472.USD","LU2237443622.USD","LU0417517546.SGD","GB00BDT5M118.USD","LU2361044949.HKD","LU0256863811.USD","LU1917777945.USD","LU2361044865.SGD","LU2756315318.SGD","IE00BJJMRZ35.SGD","BK1161","LU2750360641.GBP","IE00B2B36J28.USD","SGXZ51526630.SGD","LU0122379950.USD","LU0689472784.USD","LU1868836757.USD","LU0820562030.AUD","LU2491050071.SGD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645914863","title":"港股异动 | 和誉-B(02256)高开逾4% 附属和誉医药与礼来深化研发合作 将围绕多个疾病靶点开展创新药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2645914863","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645914863?lang=zh_cn&edition=full","pubTime":"2026-06-24 09:27","pubTimestamp":1782264464,"startTime":"0","endTime":"0","summary":"消息面上，6月24日，和誉-B发布公告，公司的附属公司上海和誉生物医药科技有限公司宣布，公司已与全球领先制药企业Eli Lilly and Company(礼来)签署战略研究合作及授权协议。根据该协议条款，和誉医药将依托其早期药物发现平台、创新研发体系及丰富的开发经验，围绕礼来选定的疾病靶点开展新药项目的发现与早期开发活动。此外，和誉医药还将有权根据此次合作产生的产品年度净销售额获得阶梯式销售分成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457892.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ELIL","LU0353189680.USD","LU2237443622.USD","LU0820561909.HKD","IE00BWXC8680.SGD","SG9999001176.USD","LU0109391861.USD","LU0198837287.USD","LU0323591593.USD","LU0079474960.USD","ELIS","LU2111349929.HKD","LU2468319806.SGD","LU2778985437.USD","LU0316494557.USD","LU2491050154.USD","LU0097036916.USD","BK4588","LU2756315664.SGD","LU0471298694.HKD","GB00BDT5M118.USD","IE0004445015.USD","IE00B4R5TH58.HKD","LU0640476718.USD","IE00BK4W5L77.USD","02256","LU1868836914.USD","IE00B2B36J28.USD","IE00BFSS7M15.SGD","LU1061106388.HKD","LU2237443465.HKD","LU0058720904.USD","BK4007","IE00B4JS1V06.HKD","LU1988902786.USD","LU0466842654.USD","LU2462157665.USD","LU2552382132.HKD","LU2112291526.USD","SG9999018865.SGD","LU0672654240.SGD","LU2237443895.HKD","IE00BKPKM429.USD","LU0289739699.SGD","LU0158827948.USD","LU1551013425.SGD","SGXZ51526630.SGD","IE00B5MMRT66.SGD","LU2168564065.EUR","LU0210536198.USD","LU2552382215.SGD","IE00BJLML261.HKD","LU0094547139.USD","SG9999014898.SGD","LU2602419157.SGD","LU0256863902.USD","IE0009355771.USD","LU2461242641.AUD","LU2471134952.CNY","LU2023250330.USD","LU2488822045.USD","LU1804176565.USD","LU0320765059.SGD","LU2750360997.AUD","BK4534","IE00BJJMRY28.SGD","LU1035775433.USD","LU2023251221.USD","LU0109394709.USD","LU2476274308.USD","LU2471134796.USD","LU1232071149.USD","SG9999015978.USD","LU2063271972.USD","LU2746668974.SGD","LU0266013472.USD","LU0353189763.USD","LU0823416689.USD","LU2265009873.SGD","LU0385154629.USD","LU0225283273.USD","LU2552382058.USD","LU0203201768.USD","LU2028103732.USD","SGXZ57979304.SGD","SG9999013999.USD","IE00BFTCPJ56.SGD","LU1989771016.USD","LU0238689110.USD","LU0823434583.USD","LU1023059063.AUD","LU1127390331.HKD","LU2491049909.HKD","LU2750360641.GBP","IE00B1XK9C88.USD","IE0004445239.USD","LLY","LU0889565916.HKD","LU1868837136.USD","LU1323610961.USD","LU1720051017.SGD","LU2168563687.JPY","LU2324357040.USD","LU2023250504.SGD","LU2896262040.SGD","SG9999015986.USD","LU0006306889.USD","SGXZ31699556.SGD","LU1720051108.HKD","IE00BK4W5M84.HKD","LU2237443549.SGD","LU0320765992.SGD","LU2106854487.HKD","LU1057294990.SGD","BK4599","IE00B1BXHZ80.USD","LU2360106947.USD","LU0106261372.USD","LU1868837300.USD","BK4585","LU0823434740.USD","LU2213496289.HKD","LU2236285917.USD","LU1291159041.SGD","LU0471298777.SGD","LU2491050071.SGD","LU2746668461.USD","LU0820561818.USD","IE0005OL40V9.USD","LU2237443978.SGD","LU2361044865.SGD","BK1161","LU0256863811.USD","LU2264538146.SGD","LU0432979614.USD","LU1814569148.SGD","LU1917777945.USD","IE00BFSS8Q28.SGD","LLYX","LU0203202063.USD","LU0882574055.USD","LU1064131342.USD","LU0787776722.HKD","LU0061475181.USD","LU2089283258.USD","LU2476274720.SGD","LU1623119135.USD","LU2361045086.USD","SG9999014914.USD","LU0683600562.USD","LU2211815571.USD","SG9999017495.SGD","LU0096364046.USD","LU0133085943.USD","LU0158827781.USD","LU1093756168.USD","LU0114720955.EUR","LU0820562030.AUD","LU0354030438.USD","SG9999001176.SGD","LU0708995401.HKD","LU2168564222.USD","LU2471134523.USD","LU2471134879.HKD","IE0002141913.USD","LU2087625088.SGD","SG9999018857.SGD","LU2756315318.SGD","SG9999015945.SGD","LU2271345857.HKD","IE00BN29S564.USD","LU1093756325.SGD","LU1983299246.USD","SG9999015952.SGD","LU1868836757.USD","LU2237438978.USD","IE00B543WZ88.USD","LU2237443382.USD","LU1974910355.USD","LU2108987350.USD","LU2168564149.EUR","LU0354030511.USD","LU0689472784.USD","LU2089984988.USD","LU0234572021.USD","LU0943347566.SGD","LU1145028129.USD","LU2361044949.HKD","LU1280957306.USD","LU1629891620.HKD","SGXZ99366536.SGD","IE0001KFT4U8.USD","LU1548497426.USD","LU2168564495.EUR","LU1551013342.USD","LU0417517546.SGD","BK4533","LU0882574139.USD","LU1069344957.HKD","LU2357305700.SGD","IE00BJT1NW94.SGD","LU0786609619.USD","LLII","LU2089284900.SGD","BK4581","SG9999014880.SGD","IE00B775H168.HKD","LU0964807845.USD","IE00BJJMRZ35.SGD","LU1267930730.SGD","LU1868836591.USD","IE00B7KXQ091.USD","IE00BKDWB100.SGD","IE00BJJMRX11.SGD","LU1712237335.SGD","SGXZ81514606.USD","LU0122379950.USD","LLYZ","LU2417539215.USD","BK4516","LU2456880835.USD","LU1366192091.USD","SG9999014906.USD","IE00BPRC5H50.USD","LU0456855351.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645639538","title":"港股开盘反弹 恒指高开0.36% 百度集团-S(09888)涨2.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645639538","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645639538?lang=zh_cn&edition=full","pubTime":"2026-06-24 09:26","pubTimestamp":1782264409,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股开盘反弹，恒指高开0.36%，国企指数高开0.42%，恒生科技指数高开0.48%。百度集团-SW涨2.96%，联想集团涨2.24%，携程集团-S涨2.18%，百济神州涨2.05%，中国生物制药涨1.83%。和誉高开4.67%，公司宣布，附属公司和誉医药与礼来签署战略研究合作及授权协议，双方将围绕多个疾病靶点开展创新药研发合作，共同推进具有全球潜力的新型候选药物。内地股市昨日反复向下，沪指收市下跌1.4%，两市成交额则保持活跃，并继续超过三万亿元。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/NGJmNWFkZDNlMDY5ZTM0ZDA3ZmU4NjQzMjc2Mzg3NzYxMw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NGJmNWFkZDNlMDY5ZTM0ZDA3ZmU4NjQzMjc2Mzg3NzYxMw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984356","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B031HY20.USD","00006","02256","LU1868837300.USD","LU1188198961.HKD","LU2746668974.SGD","LU2237443465.HKD","LU0823426480.USD","LU0049112450.USD","LU0820562030.AUD","BK1258","LU1023057109.AUD","IE0001KFT4U8.USD","LU1629891620.HKD","LU1551013425.SGD","LU0164865239.USD","LU0082770016.USD","HK0000165453.HKD","LU0203202063.USD","IE0005OL40V9.USD","LU2237443978.SGD","LU0823397285.USD","BK1095","HK0000306701.USD","IE00B4JS1V06.HKD","LNVGY","LU3063872942.SGD","LU1232071149.USD","IE00B3M56506.USD","LU0307460666.USD","LU0762542818.HKD","LU0634319403.HKD","IE0003851619.USD","07200","LU0011963245.USD","03419","GB00BDT5M118.USD","LU0054237671.USD","LU1481107354.HKD","LU0097036916.USD","LU2461242641.AUD","LU2750360997.AUD","SG9999015986.USD","SGXZ90724238.SGD","LU0463099449.HKD","BK1229","LU2328871848.SGD","BK4516","01177","LU1956131251.USD","LU1235295612.USD","LU0158827948.USD","LU0079474960.USD","LU2237438978.USD","LU2168563687.JPY","LU2324357040.USD","LU2361044865.SGD","LU0173614495.USD","BK4533","SG9999015945.SGD","LU1064131342.USD","LU0737861699.HKD","LU2756315664.SGD","LU1831875114.USD","LU0058720904.USD","LU0314109678.HKD","BK1544","LU0096364046.USD","LU0353189680.USD","LU2552382215.SGD","LU0264606111.USD","LU0432979614.USD","LU0871576103.HKD","LU1623119135.USD","80992","LU0287142896.SGD","LU2348773727.SGD","IE00BFSS8Q28.SGD","LU1720051017.SGD","BK1502","IE00BJJMRY28.SGD","LU1634259557.SGD","LU0128525689.USD","LU2237443382.USD","LU0516422366.SGD","HK0000306685.HKD","LU0329678170.USD","LU0516423091.SGD","LU2087625088.SGD","LU0605514214.HKD","LU1497734951.SGD","LU1868836914.USD","LU0261950983.USD","LU2106854487.HKD","513600","IE0032431581.USD","LU0225283273.USD","LU0786609619.USD","LU2237443895.HKD","MCHmain","BK4585","03037","LU2028103732.USD","SG9999015952.SGD","00992","LU0385154629.USD","LU2112291526.USD","LU0326950275.SGD","LU0791590937.USD","LU1093756168.USD","BK1099","LU0431992006.USD","LU0197773160.USD","HK0000320223.HKD","LU0882574055.USD","LU0228367735.SGD","LU0107464264.USD","LU1497733557.USD","LU2213496289.HKD","IE00B1BXHZ80.USD","LU1548497426.USD","LU2089283258.USD","LU1145028129.USD","09115","LU2468319806.SGD","LU0828237940.HKD","LU0502904849.HKD","IE0008369823.USD","SG9999011746.SGD","SG9999000459.SGD","01209","LU0109391861.USD","LU0211977185.USD","LU0149721374.USD","LU0052750758.USD","LU2237443549.SGD","BK1515","LU0228659784.USD","SG9999001093.SGD","BK4007","BK1609","LU0163747925.USD","LU0823434740.USD","LU2108987350.USD","LU0828238088.HKD","LU0122379950.USD","IE00B543WZ88.USD","IE00B775H168.HKD","LU2360106947.USD","LU2602419157.SGD","LU1291159041.SGD","LU2089284900.SGD","LU0370786039.SGD","SG9999001176.USD","LU0043850808.USD","IE00BK4W5M84.HKD","LU2357305700.SGD","LU0471298777.SGD","LU1328277881.USD","LU0164939612.USD","LU0006306889.USD","BIDU","LU2778985437.USD","LU0543330566.HKD","LU1102505762.USD","LU2756315318.SGD","IE00BZ08YR35.GBP","02800","LU0820561909.HKD","LU0289739699.SGD","IE00BK4W5L77.USD","LLY","LU0133085943.USD","LU1224709979.USD","LU0456846285.SGD","LU0889565916.HKD","LU2471134523.USD","SG9999014674.SGD","IE00B1XK9C88.USD","LU0762540952.USD","LU1115378108.SGD","LU2271345857.HKD","LU1634259391.SGD","LU2237443622.USD","LU0683600562.USD","LU0048575426.USD","SG9999001176.SGD","BK1604","LU0791591158.USD","LU0256863902.USD","LU1323610961.USD","LU0471298694.HKD","BK1541","IE00B8L5B284.USD","LU0630378692.HKD","LU1048596156.SGD","LU0572940350.SGD","LU0821914370.USD","LU0509642566.USD","LU0708995401.HKD","LU0466842654.USD","LU0594300179.USD","IE0034224299.USD","LU0868486357.SGD","LU1267930227.SGD","LU2750360641.GBP","SG9999018857.SGD","BK1227","IE00BKDWB100.SGD","LU1328615791.USD","BK1587","LU2236285917.USD","LU1868837136.USD","SG9999014898.SGD","LU0456855351.SGD","LU0354030511.USD","LU0823416689.USD","LU2449936058.SGD","LU1366334578.USD","LU1497733631.SGD","LU0540923850.HKD","688235","LU0831093199.SGD","LU0708995583.HKD","LU0516423174.USD","LU2023250330.USD","SG9999000418.SGD","LU0181495838.USD","LU0359201885.HKD","LLYX","LU0417517546.SGD","LU2462157665.USD","IE00BFTCPJ56.SGD","LU2023251221.USD","09633","LU2456880835.USD","LU1804176565.USD","82800","HSTECH","LU1366334651.USD","LU2168564149.EUR","LU0094547139.USD","LU0310800965.SGD","LU0823426308.USD","LU2896262040.SGD","ONC","LU1282649810.SGD","LU0588546209.SGD","BK1193","IE0004445239.USD","03115","LU0823434583.USD","IE00BJJMRX11.SGD","LU2168564222.USD","LU2488822045.USD","SG9999017495.SGD","LU0964807845.USD","LU1917777945.USD","SG9999002562.SGD","NNFSF","LU0048580855.USD","LU0828237510.HKD","LU0689472784.USD","LU1366192091.USD","LU0210536198.USD","LU1251922891.USD","LU2476274308.USD","LU2168564065.EUR","83115","LU0329678337.USD","LU1868836591.USD","LU2063271972.USD","LU0039217434.USD","IE00B4R5TH58.HKD","LU2471134879.HKD","BK1500","LU0261950470.USD","LU0819121731.USD","HK0000320264.USD","ELIS","LU0323591593.USD","BK1575","LU0640798160.USD","LU2211815571.USD","LU0114720955.EUR","LU0417516902.SGD","HHImain","BK1191","IE0003795394.USD","LU0348825331.USD","LU0238689110.USD","LU1023059063.AUD","BK4534","LU1720051108.HKD","LU2089984988.USD","SGXZ31699556.SGD","IE00BZ08YS42.EUR","LU2111349929.HKD","IE00BWXC8680.SGD","LU0650527681.SGD","LU0543330483.HKD","LU0320765059.SGD","IE0009355771.USD","LU0106261372.USD","02618","LU2264538146.SGD","06160","LU2491049909.HKD","IE00BJLML261.HKD","LU0882574139.USD","SG9999002463.SGD","LU0348735423.USD","LU2242644610.SGD","IE00B5MMRT66.SGD","07300","LU1522347837.USD","LU1069344957.HKD","LU1868836757.USD","LU2039709279.SGD","LU0640476718.USD","09888","BK1583","SG9999014880.SGD","LU0029875118.USD","LU1880383366.USD","LU0109394709.USD","LU0787776722.HKD","LU0737861772.HKD","LU2471134952.CNY","LLYZ","LU0158827781.USD","LU1983299246.USD","LU1093756325.SGD","IE00B7KXQ091.USD","LU1989771016.USD","LU1267930730.SGD","LU1813983027.USD","02460","IE00BPRC5H50.USD","LU2417539215.USD","BK1588","IE00BKPKM429.USD","LU1127390331.HKD","LU0354030438.USD","ELIL","LU2361045086.USD","LU0128522157.USD","LU0082770016.SGD","LU2265009873.SGD","LU0072462343.USD","LU0943347566.SGD","02833","LU0672654166.SGD","LU2424517915.HKD","IE0008368742.USD","LU0164880469.USD","LU0856984785.SGD","LU0359201612.USD","LU0269904917.USD","06181","BK4581","SGXZ99366536.SGD","SG9999015978.USD","LU2552382058.USD","LU0456827905.SGD","LU0266013472.USD","LU0231483743.USD","LU1551013342.USD","LU1102505929.USD","IE00B2B36J28.USD","07500","LU0455707207.USD","SGXZ57979304.SGD","LU1712237335.SGD","LU1814569148.SGD","LU0198837287.USD","LU2153591404.USD","SG9999018865.SGD","SGXZ51526630.SGD","BK1527","LU2023250504.SGD","LU1057294990.SGD","LU0061475181.USD","LU1988902786.USD","LU0316494557.USD","09961","LU0823397103.USD","LU0353189763.USD","LU0234572021.USD","IE0004445015.USD","LU0384037296.USD","LU0531971595.HKD","IE00BJT1NW94.SGD","LU0203201768.USD","LU0516422440.USD","LU2361044949.HKD","LU1061106388.HKD","LU0052756011.USD","BK1542","BK1526","BK1161","BK1200","LU0197773673.USD","LU2491050154.USD","89888","HSI","LU1303224171.USD","LU1981816686.USD","BK1615","LU1770034418.SGD","LU2552382132.HKD","LU0320765992.SGD","BK4599","LU1035775433.USD","LU1880383440.USD","LU1046422090.SGD","IE00B8HQ1Z84.USD","LU0630378429.USD","LU0516422952.EUR","LU1280957306.USD","BK1151","LU0820561818.USD","LU0051755006.USD","SG9999002828.SGD","LU0762541174.USD","IE0002141913.USD","LU0672654240.SGD","LU0417516738.SGD","HGKGY","IE00BZ08YT58.USD","LU1282649067.USD","BK4588","IE00B0JY6N72.USD","SG9999001903.USD","BK1607","LU0594300419.USD","IE00BFSS7M15.SGD","LU0488056044.USD","IE00BJJMRZ35.SGD","IE00BN29S564.USD","LU0320764599.SGD","LU2476274720.SGD","LU1048588211.SGD","SG9999014914.USD","LU2168564495.EUR","SGXZ81514606.USD","LU0320764755.SGD","BK1521","LU0244354667.USD","LU0229945570.USD","LU1719994722.HKD","LU2471134796.USD","LU0315179316.USD","SG9999001051.SGD","TCOM","LU0572939691.SGD","SG9999000475.SGD","LLII","LU2746668461.USD","SG9999013999.USD","BK1589","LU1969619763.USD","LU0251143458.SGD","BK1164","LU0256863811.USD","LU2491050071.SGD","BK1569","LU0359202008.SGD","LU1808992512.USD","SG9999014906.USD","SBHMY","LU1974910355.USD","LU0620787316.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645850611","title":"和誉-B(02256)附属和誉医药与礼来深化研发合作 共同推进具有全球潜力的新型候选药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2645850611","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645850611?lang=zh_cn&edition=full","pubTime":"2026-06-24 08:09","pubTimestamp":1782259756,"startTime":"0","endTime":"0","summary":"和誉医药与礼来将利用各自在药物发现、研发及全球开发方面的优势，致力于加速推进创新治疗方案，并为全球患者带来新的治疗方案。2022年，和誉医药与礼来签署全球合作及独家许可协议，就新型小分子治疗药物的发现、开发及潜在商业化开展合作。此次与礼来的合作有望推动多个创新项目，进一步增强公司全球化创新战略和长期价值创造潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457859.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0002141913.USD","LU2028103732.USD","LU0787776722.HKD","LU1023059063.AUD","LU2471134879.HKD","IE0005OL40V9.USD","LU2417539215.USD","LU0106261372.USD","LU2211815571.USD","IE00BFSS8Q28.SGD","LU0640476718.USD","LU1551013342.USD","LU2237443895.HKD","LU2746668461.USD","LU1551013425.SGD","SG9999018857.SGD","LU0823434740.USD","LU2491050154.USD","LU0320765992.SGD","LU0889565916.HKD","SGXZ99366536.SGD","LU0234572021.USD","LU2168564495.EUR","SG9999015978.USD","SGXZ57979304.SGD","SG9999017495.SGD","LU2488822045.USD","LU0320765059.SGD","SG9999015986.USD","LU0354030438.USD","LU2552382215.SGD","LU2106854487.HKD","LU0820561909.HKD","LU2089984988.USD","IE00B1XK9C88.USD","LU1720051017.SGD","LU0708995401.HKD","LU0417517546.SGD","IE00B543WZ88.USD","SG9999013999.USD","LU2361045086.USD","LU0094547139.USD","LU2357305700.SGD","LU2461242641.AUD","BK4007","LU0471298694.HKD","LU0689472784.USD","LU1868837136.USD","LU1064131342.USD","LU2168564149.EUR","LU1267930730.SGD","BK4534","LU1280957306.USD","LU2237443465.HKD","SG9999018865.SGD","IE0004445239.USD","LU0323591593.USD","LU2213496289.HKD","IE00B5MMRT66.SGD","LLYZ","LU2746668974.SGD","LU1989771016.USD","LU2265009873.SGD","LU1868836914.USD","LU0432979614.USD","LU2361044865.SGD","LU1868836757.USD","LU2468319806.SGD","LU1323610961.USD","SG9999014914.USD","LU0964807845.USD","LU0316494557.USD","IE00B7KXQ091.USD","LU2168564222.USD","LU0198837287.USD","LU0158827948.USD","IE00BJT1NW94.SGD","LU0672654240.SGD","BK4599","IE00BFSS7M15.SGD","IE00BPRC5H50.USD","LU1814569148.SGD","LU1868837300.USD","LU2361044949.HKD","LU1720051108.HKD","SG9999014880.SGD","SG9999015952.SGD","LU0203202063.USD","SG9999001176.SGD","LU2089283258.USD","LU1623119135.USD","IE00BJJMRY28.SGD","LU0006306889.USD","LU0820562030.AUD","SGXZ51526630.SGD","IE0009355771.USD","LU0114720955.EUR","LU2750360997.AUD","IE00BKPKM429.USD","LU2087625088.SGD","SG9999014898.SGD","LU1232071149.USD","LU2491050071.SGD","LU0158827781.USD","LU2471134952.CNY","LU2168563687.JPY","LU2023250330.USD","LU0210536198.USD","LU1035775433.USD","LU2237443622.USD","LU1629891620.HKD","LU1145028129.USD","LU2023250504.SGD","LU2023251221.USD","LU2063271972.USD","LU0079474960.USD","LU1917777945.USD","LU2756315664.SGD","LU0203201768.USD","LU0109391861.USD","LU2237443382.USD","LU1868836591.USD","LU0820561818.USD","LU2271345857.HKD","IE0004445015.USD","LU1974910355.USD","LU0109394709.USD","LU1069344957.HKD","LU0238689110.USD","LU2237438978.USD","IE00BN29S564.USD","LU1804176565.USD","LU0061475181.USD","IE00B2B36J28.USD","LU2236285917.USD","SG9999001176.USD","LU2456880835.USD","LU0097036916.USD","LU0823416689.USD","LLY","LU0122379950.USD","LU2471134523.USD","ELIL","LU2471134796.USD","LU2756315318.SGD","BK4585","BK4588","LU1093756325.SGD","LU0289739699.SGD","IE00B4JS1V06.HKD","LLYX","SGXZ31699556.SGD","LU0683600562.USD","IE00B775H168.HKD","LU0456855351.SGD","LU2237443549.SGD","LU2476274720.SGD","LU0786609619.USD","LU0353189763.USD","LU2112291526.USD","LU2491049909.HKD","LU2476274308.USD","LU0882574055.USD","GB00BDT5M118.USD","BK1161","IE00BK4W5M84.HKD","LU2462157665.USD","LU0256863811.USD","SG9999015945.SGD","BK4581","LU0882574139.USD","LU0943347566.SGD","IE00BJJMRX11.SGD","LU2089284900.SGD","LU2778985437.USD","LLII","LU2896262040.SGD","LU0058720904.USD","SGXZ81514606.USD","LU1057294990.SGD","LU0354030511.USD","LU0133085943.USD","LU2237443978.SGD","LU2552382058.USD","LU0385154629.USD","IE00BJLML261.HKD","LU2168564065.EUR","IE00BWXC8680.SGD","LU0256863902.USD","LU1988902786.USD","LU2264538146.SGD","LU2602419157.SGD","LU0471298777.SGD","IE00BJJMRZ35.SGD","SG9999014906.USD","LU2108987350.USD","LU1712237335.SGD","IE00BFTCPJ56.SGD","LU2750360641.GBP","LU0266013472.USD","LU1548497426.USD","IE00BKDWB100.SGD","LU0823434583.USD","LU0466842654.USD","LU1127390331.HKD","LU1983299246.USD","LU2552382132.HKD","02256","IE00B1BXHZ80.USD","LU0096364046.USD","LU1061106388.HKD","LU2324357040.USD","IE0001KFT4U8.USD","BK4516","LU1093756168.USD","LU2111349929.HKD","IE00BK4W5L77.USD","IE00B4R5TH58.HKD","LU2360106947.USD","LU1291159041.SGD","LU0225283273.USD","LU1366192091.USD","ELIS","BK4533","LU0353189680.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116685255","title":"和誉-B：2026年6月23日回购6万股股份，总额约54.40万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1116685255","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116685255?lang=zh_cn&edition=full","pubTime":"2026-06-23 17:36","pubTimestamp":1782207412,"startTime":"0","endTime":"0","summary":"2026年6月23日，和誉-B发布翌日披露报表，公告当日于香港联交所场内回购股份，涉及已发行股本变动。回购价格区间介乎每股8.80港元至9.43港元，合计耗资约54.40万港元。完成回购后，公司于2026年6月23日收市时的已发行股本为716,131,350股，库存股份增至8,074,000股，公司已发行股本总数为724,205,350股。根据公告，2026年5月20日公司已通过股份购回授权，获准回购股票总数为71,646,135股。本公告由联席公司秘书张菡兮签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"和誉-B：2026年6月23日回购6万股股份，总额约54.40万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111888286","title":"和誉-B回购6.00万股股份，耗资约53.58万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1111888286","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111888286?lang=zh_cn&edition=full","pubTime":"2026-06-22 17:56","pubTimestamp":1782122194,"startTime":"0","endTime":"0","summary":"和誉开曼有限责任公司于2026年6月22日发布公告，披露公司在香港联交所场内回购6.00万股普通股。本次回购股份数量占当日前公司已发行股本约0.00838%。回购价格区间为每股8.88港元至8.99港元，合计支付约53.58万港元。此次回购完成后，公司已发行股本由716,251,350股变更为716,191,350股，库藏股数量由7,954,000股增加至8,014,000股，总股本维持724,205,350股。公司确认，本次回购股份已符合香港联合交易所有限公司证券上市规则及相关法律法规的要求，并已获董事会正式授权批准。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"和誉-B回购6.00万股股份，耗资约53.58万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645023776","title":"和誉-B(02256)6月22日斥资53.58万港元回购6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645023776","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645023776?lang=zh_cn&edition=full","pubTime":"2026-06-22 17:53","pubTimestamp":1782122020,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，于2026年6月22日斥资53.58万港元回购6万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1456978.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2778985437.USD","BK1161","LU2476274308.USD","IE00B543WZ88.USD","02256","IE00B5MMRT66.SGD","LU2476274720.SGD","LU2488822045.USD","IE00BPRC5H50.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645486290","title":"中国原研新药匹米替尼加拿大获批上市 和誉医药(02256)全球商业化进入兑现期","url":"https://stock-news.laohu8.com/highlight/detail?id=2645486290","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645486290?lang=zh_cn&edition=full","pubTime":"2026-06-22 11:15","pubTimestamp":1782098119,"startTime":"0","endTime":"0","summary":"回顾合作历程，2023年底双方签署独家许可协议；随后默克进一步行使全球商业化选择权，使匹米替尼成为和誉医药全球化战略中率先进入价值释放阶段的核心资产。匹米替尼连续获得中国和加拿大上市批准，某种程度上正代表这一逻辑的演进——创新药价值不再停留在临床数据，而开始进入商业兑现阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1456760.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2778985437.USD","IPOS","BK1161","LU2476274720.SGD","159938","BK1574","BK1515","IE00BPRC5H50.USD","IE00B5MMRT66.SGD","LU2488822045.USD","02256","IE00B543WZ88.USD","LU2476274308.USD","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642460346","title":"和誉-B(02256)6月9日斥资72.21万港元回购8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642460346","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642460346?lang=zh_cn&edition=full","pubTime":"2026-06-09 20:36","pubTimestamp":1781008600,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，于2026年6月9日斥资72.21万港元回购8万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452194.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LU2476274308.USD","LU2476274720.SGD","IE00BPRC5H50.USD","02256","LU2488822045.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU2778985437.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abbisko.com","stockEarnings":[{"period":"1week","weight":0.0365},{"period":"1month","weight":-0.112},{"period":"3month","weight":-0.2482},{"period":"6month","weight":-0.3004},{"period":"1year","weight":-0.0895},{"period":"ytd","weight":-0.2806}],"compareEarnings":[{"period":"1week","weight":-0.0524},{"period":"1month","weight":-0.1049},{"period":"3month","weight":-0.0914},{"period":"6month","weight":-0.1219},{"period":"1year","weight":-0.068},{"period":"ytd","weight":-0.1154}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"和誉开曼有限责任公司是一家临床阶段生物制药公司。该公司致力于发现和开发创新差异化的小分子肿瘤疗法。该公司拥有两款核心候选产品ABSK011和 ABSK091，以及12款其他在研产品。ABSK011是一种强效且高选择性的成纤维细胞生长因子受体4(FGFR4) 小分子抑制剂。ABSK091 是一种分子靶向候选产品，也是 FGFR亚型 1、2和3的强效和选择性抑制剂。该公司的产品主要用于肝细胞癌(HCC)、尿路上皮癌(UC) 和胃癌(GC)。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.122249},{"month":2,"riseRate":0.8,"avgChangeRate":0.040621},{"month":3,"riseRate":0.4,"avgChangeRate":0.033777},{"month":4,"riseRate":0.4,"avgChangeRate":0.005698},{"month":5,"riseRate":0.2,"avgChangeRate":-0.025571},{"month":6,"riseRate":0.4,"avgChangeRate":-0.002527},{"month":7,"riseRate":0.75,"avgChangeRate":0.047273},{"month":8,"riseRate":0.5,"avgChangeRate":0.114048},{"month":9,"riseRate":0.75,"avgChangeRate":0.043844},{"month":10,"riseRate":0.5,"avgChangeRate":-0.043137},{"month":11,"riseRate":0.6,"avgChangeRate":0.159978},{"month":12,"riseRate":0,"avgChangeRate":-0.092694}],"exchange":"SEHK","name":"和誉-B","nameEN":"ABBISKO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和誉-B(02256)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和誉-B(02256)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和誉-B,02256,和誉-B股票,和誉-B股票老虎,和誉-B股票老虎国际,和誉-B行情,和誉-B股票行情,和誉-B股价,和誉-B股市,和誉-B股票价格,和誉-B股票交易,和誉-B股票购买,和誉-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和誉-B(02256)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和誉-B(02256)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}